Denise Bevers is Director at Kindred Biosciences, Inc. (KIN). They have made 4 open-market trades across 1 company since 2020, most recently 2021-08-27.
CIK 0001593865
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KIN | 8,396 | $78K |
Shares reported on the most recent Form 4, priced at the 2021-03-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KIN | SELL · 10b5-1 | 2021-03-17 | 2021-03-18 | $5.00 | $42K | -5.2% | -2.7% | +93.1% |
| KIN | SELL · 10b5-1 | 2021-02-19 | 2021-02-23 | $5.00 | $23K | -0.2% | -5.2% | +0.2% |
| KIN | SELL | 2021-01-14 | 2021-01-15 | $5.00 | $65K | -0.8% | +4.8% | -1.4% |
| KIN | SELL | 2021-01-07 | 2021-01-08 | $5.00 | $195K | -10.1% | +8.7% | +1.6% |
| KIN | SELL | 2020-10-07 | 2020-10-08 | $5.01 | $125K | -16.7% | -24.1% | -1.6% |
| KIN | SELL | 2020-09-22 | 2020-09-24 | $5.00 | $3K | -2.6% | -12.4% | -1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.